Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Home
Menu
JOIN
SI Premium
Ratings
Mergers
Earnings
Dividends
IPOs
Hedge Funds
Premium Letters
Send a Tip
API/Data
JOIN
SI Premium
Full Feed View
Headline View
SI Premium Squawk Box
Alerts
Custom Headlines
Upgrade Your Current Account
API
Calendars
Co. NDR/Event Calendar
Dividend Calendar
Earnings Calendar
Event Driven
FDA Calendar
Investor Conferences
IPO Calendar
Merger Arb
Ratings Calendar
Stock Split Calendar
Ratings
Analyst Comments
Hot Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades
New Coverage News
Hot New Coverage
Upgrade News
Hot Upgrades
More...
Mergers
Merger News
Hot M&A News
Private Equity
Rumors
SPAC News
Spinoffs
Merger Arbitrage
Event Driven
2021 Top M&A Deals
Top 50 Takeover Targets
More...
Earnings
Earnings Calendar
Earnings News
Hot Earnings
Guidance
Hot Guidance
Conference Calls
Earnings History Search
More...
Dividends
Dividend Calendar
Dividend News
Hot Dividends
Dividend Hike
Special Dividends
Stock Buybacks
Hot Stock Buybacks
Stock Splits
More...
IPOs
IPO News
Hot IPOs
Equity Offerings
Recent IPOs
Upcoming IPOs
2021 Top IPOs
More...
Hedge Funds
13D
13F
13G
Hedge Funds News
Hot Insider Trades
Insider Trades
More...
Premium Letters
Pulse Picks
Stealth Growth Insider
Send a Tip
API/Data
QUICK LINKS :
Goldman Sachs Conviction Buy List
Warren Buffett News
Elliott Management News
Follow @Street_Insider
Premium Content
Top News
Wall St set to gain on tech rebound, Middle East in focus
Oracle results beat estimates, but shares fall on plans for $40 billion raise
Oil prices steady as investors weigh US-Iran war escalation
Market Snapshot
Nasdaq
S&P 500
Nasdaq
15000.33
+57.68
(+0.39%)
S&P 500
4486.55
+7.02
(+0.16%)
Quotes delayed at least 20 mins.
Send to a Friend
Font Size:
Increase
Decrease
GMED and IMRX Related Headlines
Go Back
Jan 7, 2026 04:59PM
After-hours movers: Lockheed Martin, Canadian Solar, Revolution Medicines and more
GMED and IMRX Related Press Releases
Go Back
GMED and IMRX Related SEC Filings
Go Back
